Abstract:Atrial natriuretic peptide (ANP), a small peptide consisting of 28 amino acids, has been applied in clinical treatment for heart failure, but it can encounter proteolytic degradation during its expression in host cells. Therefore, it is usually reported that ANP was expressed as a part of fusion protein. The aim of our study was to use an overexpression system to express the fusion protein REF-ANP and to optimize a purification method. First, Escherichia coli DH5alpha was transformed with constructed expression vector containing two tandem copies of ref-anp gene and the fusion protein REF-ANP was overexpressed in shaking flask culture. Subsequently, the inclusion bodies were purified with reverse phase chromatography and pooled fractions were lyophilized. After this step, REF-ANP can be solubilized under native conditions without urea. After cleavage reaction, the sample was subjected to size exclusion chromatography and then rANP was polished with reverse phase chromatography. The final purity of rANP was more than 98% and the recovery of rANP per liter of shaking flask culture was more than 3mg. Such methods as mass spectrometry, capillary isoelectrofocusing analysis, and N-terminal amino acid sequence were used to identify rANP. The capillary isoelectrofocusing analysis showed that the pI of ANP was about pH 9.7. In this study, an efficient refolding and purification process should make scaling-up procedures easier and more successful than earlier reports. Moreover, it is possible that the refolding and purification method along with the overexpression system described in this article may offer new ideas on optimizing expression and purification of other kinds of short peptides.

Refolding and Biological Activity Determination of Recombinant Human DNaseⅠ

Refolding of recombinant human interferon-gamma by expanded bed adsorption chromatography with urea gradient

Downstream processes for recombinant human DNase Ⅰ from two different expression patterns in Escherichia coli

Expression, Purification, and Refolding of a Recombinant Human Bone Morphogenetic Protein 2 in Vitro

Downstream processes for recombinant human DNase I from two different expression patterns in Escherichia coli

Purification and Refolding Escherichia Coli Produced Enterokinase Inclusion Bodies Immobilized by Nickel Chelating Chromatography

Refolding and two-step purification by hydrophobic interaction chromatography of recombinant human bone morphogenetic protein-2 from Escherichia coli

Overexpression and Purification of Recombinant Atrial Natriuretic Peptide Using Hybrid Fusion Protein REF-ANP in Escherichia Coli

Refolding of ribonuclease A in vitro and conformational characterization by spectrofluorimetry

One-step refolding and purification of recombinant human tumor necrosis factor-α (rhTNF-α) using ion-exchange chromatography.

Development of A Novel Refolding Method Using Inclusion Bodies from Green Fluorescent Protein

Refolding and Purification of Recombined Human Endostatin Using Cation Exchange Chromatography

Highly Efficient Production of Soluble Proteins from Insoluble Inclusion Bodies by a Two-Step-denaturing and Refolding Method.

Research on Renaturation of Recombinant Human Kallikrein from E.coli

Purification, Refolding of Hybrid Hifnγ-Kringle 5 Expressed in Escherichia Coli

Expression, purification and refolding of pro-MMP-2 from inclusion bodies of E. coli

High-Level Expression and Purification of Recombinant Heparinase Ⅰ in Escherichia Coli

[The Renaturation and Purification of RGD-staphylokinase by Gel Filtration].

The mechanism of PNIPAAm-assisted refolding of lysozyme denatured by urea

Surfactant Assisted Refolding of Recombinant Proteins

Protein refolding based on high hydrostatic pressure and alkaline pH: Application on a recombinant dengue virus NS1 protein